DK1423371T3 - Triazinderivater og anvendelse deraf som solbeskyttelse - Google Patents
Triazinderivater og anvendelse deraf som solbeskyttelseInfo
- Publication number
- DK1423371T3 DK1423371T3 DK02772133.1T DK02772133T DK1423371T3 DK 1423371 T3 DK1423371 T3 DK 1423371T3 DK 02772133 T DK02772133 T DK 02772133T DK 1423371 T3 DK1423371 T3 DK 1423371T3
- Authority
- DK
- Denmark
- Prior art keywords
- sub
- alkyl
- unsubstituted
- substituted
- alkoxy
- Prior art date
Links
- 150000003918 triazines Chemical class 0.000 title abstract 2
- 230000037072 sun protection Effects 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 3
- 125000003545 alkoxy group Chemical group 0.000 abstract 3
- -1 amino- Chemical class 0.000 abstract 3
- 125000003118 aryl group Chemical group 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000004356 hydroxy functional group Chemical group O* 0.000 abstract 3
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 125000001960 7 membered carbocyclic group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 125000000392 cycloalkenyl group Chemical group 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 125000001453 quaternary ammonium group Chemical group 0.000 abstract 1
- 239000000516 sunscreening agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4966—Triazines or their condensed derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
- C07D251/16—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
- C07D251/18—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with nitrogen atoms directly attached to the two other ring carbon atoms, e.g. guanamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/40—Nitrogen atoms
- C07D251/54—Three nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/40—Nitrogen atoms
- C07D251/54—Three nitrogen atoms
- C07D251/70—Other substituted melamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Toxicology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cosmetics (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01810796 | 2001-08-17 | ||
| CH16992001 | 2001-09-14 | ||
| PCT/EP2002/008888 WO2003016289A1 (en) | 2001-08-17 | 2002-08-08 | Triazine derivatives and their use as sunscreens |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1423371T3 true DK1423371T3 (da) | 2011-02-07 |
Family
ID=25739004
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK02772133.1T DK1423371T3 (da) | 2001-08-17 | 2002-08-08 | Triazinderivater og anvendelse deraf som solbeskyttelse |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7038046B2 (enExample) |
| EP (1) | EP1423371B1 (enExample) |
| JP (1) | JP4344241B2 (enExample) |
| AT (1) | ATE485281T1 (enExample) |
| DE (1) | DE60238066D1 (enExample) |
| DK (1) | DK1423371T3 (enExample) |
| WO (1) | WO2003016289A1 (enExample) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6748471B1 (en) * | 2000-10-16 | 2004-06-08 | Electronics For Imaging, Inc. | Methods and apparatus for requesting and receiving a print job via a printer polling device associated with a printer |
| US7574545B2 (en) * | 2000-10-16 | 2009-08-11 | Electronics For Imaging, Inc. | Method and apparatus for controlling a document output device with a control request stored at a server |
| FR2867188A1 (fr) * | 2004-03-03 | 2005-09-09 | Oreal | Derives de s-triazine possedant un groupement para-alcoxyphenyle et au moins un groupement aminobenzalmaloniques greffes ; compositions cosmetiques contenant ces derives; utilisations desdits derives de s-tri |
| US20070286827A1 (en) * | 2006-06-12 | 2007-12-13 | Esschem, Inc. | Optical brighter and uv stabilizer for acrylic enhancements |
| US20080026109A1 (en) * | 2006-06-29 | 2008-01-31 | Martek Biosciences Corporation | Sweetened Oil Compositions and Methods of Making |
| ATE527982T1 (de) * | 2006-08-24 | 2011-10-15 | Unilever Nv | Fotostabile kosmetische zusammensetzungen |
| US20080096782A1 (en) * | 2006-10-19 | 2008-04-24 | L'oreal | Aqueous systems containing phospholipid, surfactant and phosphate ester for water-insoluble materials |
| US20080097070A1 (en) * | 2006-10-19 | 2008-04-24 | L'oreal | Aqueous polyamine-containing systems for water-insoluble materials |
| MX346801B (es) | 2009-03-13 | 2017-03-31 | Agios Pharmaceuticals Inc | Métodos y composiciones para trastornos relacionados con la proliferación celular. |
| SG177434A1 (en) | 2009-06-29 | 2012-02-28 | Agios Pharmaceuticals Inc | Therapeutic compounds and compositions |
| WO2011050210A1 (en) | 2009-10-21 | 2011-04-28 | Agios Pharmaceuticals, Inc. | Methods and compositions for cell-proliferation-related disorders |
| US9539193B2 (en) | 2010-05-10 | 2017-01-10 | Gfbiochemicals Limited | Alkyl ketal esters as dispersants and slip agents for particulate solids, methods of manufacture, and uses thereof |
| TWI519569B (zh) | 2010-12-28 | 2016-02-01 | Nissan Chemical Ind Ltd | A coating solution for forming a polyimide film, a liquid crystal aligning agent, a polyimide film, a liquid crystal alignment film, and a liquid crystal display element |
| US9040030B2 (en) * | 2010-12-30 | 2015-05-26 | L'oreal | Mascara compositions containing an oil-dispersible micronized wax and a water-dispersible wax |
| PT2704721T (pt) | 2011-05-03 | 2018-06-14 | Agios Pharmaceuticals Inc | Ativadores da piruvato-cinase para utilização em terapia |
| CN102827170A (zh) | 2011-06-17 | 2012-12-19 | 安吉奥斯医药品有限公司 | 治疗活性组合物和它们的使用方法 |
| CN102827073A (zh) | 2011-06-17 | 2012-12-19 | 安吉奥斯医药品有限公司 | 治疗活性组合物和它们的使用方法 |
| UA117451C2 (uk) | 2012-01-06 | 2018-08-10 | Аджиос Фармасьютікалз, Інк. | Терапевтично активні сполуки і способи їх застосування |
| US9474779B2 (en) | 2012-01-19 | 2016-10-25 | Agios Pharmaceuticals, Inc. | Therapeutically active compositions and their methods of use |
| WO2014062511A1 (en) | 2012-10-15 | 2014-04-24 | Agios Pharmaceuticals, Inc. | Therapeutic compounds and compositions |
| US9724350B2 (en) | 2013-07-11 | 2017-08-08 | Agios Pharmaceuticals, Inc. | N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as IDH2 mutants inhibitors for the treatment of cancer |
| WO2015003360A2 (en) * | 2013-07-11 | 2015-01-15 | Agios Pharmaceuticals, Inc. | Therapeutically active compounds and their methods of use |
| WO2015003355A2 (en) | 2013-07-11 | 2015-01-15 | Agios Pharmaceuticals, Inc. | Therapeutically active compounds and their methods of use |
| US9579324B2 (en) | 2013-07-11 | 2017-02-28 | Agios Pharmaceuticals, Inc | Therapeutically active compounds and their methods of use |
| WO2015006591A1 (en) | 2013-07-11 | 2015-01-15 | Agios Pharmaceuticals, Inc. | 2,4- or 4,6-diaminopyrimidine compounds as idh2 mutants inhibitors for the treatment of cancer |
| US20150031627A1 (en) | 2013-07-25 | 2015-01-29 | Agios Pharmaceuticals, Inc | Therapeutically active compounds and their methods of use |
| UA121211C2 (uk) | 2014-03-14 | 2020-04-27 | Аджіос Фармасьютикалз, Інк. | Фармацевтична композиція, що містить тверду дисперсію, та спосіб лікування гострої мієлогенної/мієлоїдної лейкемії (гмл) |
| SI3307271T1 (sl) | 2015-06-11 | 2023-11-30 | Agios Pharmaceuticals, Inc. | Postopki za uporabo aktivatorjev piruvat kinaze |
| MD3362065T2 (ro) | 2015-10-15 | 2024-08-31 | Servier Lab | Terapie combinată care conține ivosidenib, citarabină și daunorubicina sau idarubicina pentru tratarea leucemiei acute mielogene |
| DK3362066T3 (da) | 2015-10-15 | 2021-11-22 | Les Laboratoires Servier Sas | Kombinationsterapi til behandling af maligniteter |
| CN107827764A (zh) * | 2017-11-27 | 2018-03-23 | 上海应用技术大学 | 一种双β‑氨基酮或双β‑氨基酯类的制备方法 |
| US10980788B2 (en) | 2018-06-08 | 2021-04-20 | Agios Pharmaceuticals, Inc. | Therapy for treating malignancies |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4105923A1 (de) | 1991-02-26 | 1992-08-27 | Basf Ag | P-aminozimtsaeure-substituierte triazine |
| DE4223890A1 (de) * | 1992-02-19 | 1993-08-26 | Merck Patent Gmbh | Triazin-derivate |
| FR2744721B1 (fr) * | 1996-02-12 | 1999-06-18 | Oreal | Nouveaux derives insolubles de s-triazine, leur procede de preparation, compositions les contenant et leurs utilisations |
-
2002
- 2002-08-08 AT AT02772133T patent/ATE485281T1/de not_active IP Right Cessation
- 2002-08-08 JP JP2003521215A patent/JP4344241B2/ja not_active Expired - Fee Related
- 2002-08-08 DE DE60238066T patent/DE60238066D1/de not_active Expired - Lifetime
- 2002-08-08 EP EP02772133A patent/EP1423371B1/en not_active Expired - Lifetime
- 2002-08-08 DK DK02772133.1T patent/DK1423371T3/da active
- 2002-08-08 WO PCT/EP2002/008888 patent/WO2003016289A1/en not_active Ceased
- 2002-08-08 US US10/486,761 patent/US7038046B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP4344241B2 (ja) | 2009-10-14 |
| EP1423371A1 (en) | 2004-06-02 |
| US20040242579A1 (en) | 2004-12-02 |
| WO2003016289A1 (en) | 2003-02-27 |
| ATE485281T1 (de) | 2010-11-15 |
| JP2005501855A (ja) | 2005-01-20 |
| EP1423371B1 (en) | 2010-10-20 |
| DE60238066D1 (de) | 2010-12-02 |
| US7038046B2 (en) | 2006-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1423371T3 (da) | Triazinderivater og anvendelse deraf som solbeskyttelse | |
| HUP0203841A2 (en) | 5-membered heteroaromatic compounds and use thereof for preparation of pharmaceutical compositions, and pharmaceutical compositions containing them | |
| MY129590A (en) | 8-PHENYL-6,9-DIHYDRO-[1,2,4]TRIAZOLO[3,4-i]PURIN-5-ONE DERIVATIVES | |
| JP2005538072A5 (enExample) | ||
| BR9908764A (pt) | Composto e seus sais farmaceuticamente aceitáveis ou ésteres hidrolisáveis in vivo, uso destes, processo para prepará-los, e, composição farmacêutica | |
| PT671161E (pt) | Ectoina e derivados de ectoina como distribuidor de humidade em produtos cosmeticos | |
| ES2150353A1 (es) | Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos. | |
| HUP0400757A2 (hu) | Protein kináz gátló hatású kondenzált pirazolszármazékok és ezeket tartalmazó gyógyszerkészítmények | |
| ES2132216T3 (es) | Nuevos derivados de amidinas, su preparacion y utilizacion como medicamentos con efecto antagonista de ltb4. | |
| BR0108679A (pt) | Novos compostos | |
| JP2005501855A5 (enExample) | ||
| AR022860A1 (es) | Derivados de camptotecina que poseen actividad antitumoral | |
| HUP0100064A2 (hu) | Amidszármazékot és klórtalonilt tartalmazó, szinergetikus fungicid kombináció és alkalmazása | |
| HUP0104177A2 (hu) | HIV-vírus szaporodását gátló pirimidin-származékok, eljárás az előállításukra, illetve ezeket tartalmazó gyógyászati készítmények | |
| GEP20022653B (en) | Processes and Intermediates for Preparing Anti-Cancer Compounds | |
| FI865233A0 (fi) | Pyrazolinderivat, deras framstaellning och anvaendning som medel med insekticid och akaricid verkan. | |
| BG100069A (bg) | Амидинови производни,съдържащи хетероциклични групи,получаване и приложението им | |
| HUP0402261A2 (hu) | Piperidinszármazékok és alkalmazásuk kemokin receptor aktivitás modulátoraiként, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| NO20061839L (no) | Benzimidazolderivater, sammensetninger inneholdende dem, fremstilling derav, og anvendelse derav | |
| DE60001586D1 (de) | Diphenyl-piperidin derivate | |
| AR000080A1 (es) | Nuevos derivados de triorganosilano de benzotriazoles, su uso como filtros solares, composiciones cosmeticas fotoprotectoras que los contienen y procedimiento para la proteccion de la piel y/o los cabellos contra la radiacion uv mediante los mismos. | |
| ES2189941T3 (es) | Derivados de nucleosidos aciclicos. | |
| ES2104952T3 (es) | Derivados de nitroanilina y su uso como agentes antitumorales. | |
| AR024904A1 (es) | Derivados de pirrol heteroaril sustituidos, su preparacion y sus usos terapeuticos. | |
| HUP0303204A2 (hu) | 1-Metilkarbapenem-származékok és ezeket tartalmazó gyógyszerkészítmények |